Kodiak Sciences announces treatment of first patients in Phase3 Tarcocimab study
PremiumThe FlyKodiak Sciences announces treatment of first patients in Phase3 Tarcocimab study
6M ago
Is KOD a Buy, Before Earnings?
Premium
Pre-Earnings
Is KOD a Buy, Before Earnings?
6M ago
Kodiak Sciences price target raised to $5 from $3 at UBS
Premium
The Fly
Kodiak Sciences price target raised to $5 from $3 at UBS
7M ago
Kodiak Sciences (KOD) Q4 Earnings Cheat Sheet
PremiumPre-EarningsKodiak Sciences (KOD) Q4 Earnings Cheat Sheet
8M ago
Capital One says buy these six biotech stocks for 2024
Premium
The Fly
Capital One says buy these six biotech stocks for 2024
10M ago
Capital One says buy these six biotech stocks for 2024
Premium
The Fly
Capital One says buy these six biotech stocks for 2024
10M ago
Kodiak Sciences reports Q3 EPS (95c) with items, consensus ($1.21)
PremiumThe FlyKodiak Sciences reports Q3 EPS (95c) with items, consensus ($1.21)
12M ago
KOD Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
KOD Earnings this Week: How Will it Perform?
12M ago
Kodiak Sciences announces Phase 3 GLOW superiority study met primary endpoint
Premium
The Fly
Kodiak Sciences announces Phase 3 GLOW superiority study met primary endpoint
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100